Drug-sensitive TB
Showing 1 - 25 of >10,000
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)
Recruiting
- Tuberculosis
- GSK3036656
- +3 more
-
Cape Town, South AfricaGSK Investigational Site
Jan 24, 2023
d to Treat Drug Sensitive Tuberculosis in Breastfeeding
Recruiting
- Tuberculosis Active
- +2 more
- First line tuberculosis treatment
-
Kampala, UgandaInfectious Diseases Institute
Apr 22, 2023
Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and
Not yet recruiting
- Pulmonary Tuberculosis
- Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
- +3 more
- (no location specified)
Jul 25, 2023
Clinical Evaluation of tNGS for Diagnosis of DR-TB
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- targeted Next Generation Sequencing (tNGS)
-
Tbilisi, Georgia
- +2 more
Jan 23, 2023
Promoting Engagement in Drug Resistant TB/HIV Care Continuum in
Completed
- Patient Non-compliance
-
Durban, Kwa-Zulu Natal, South AfricaKing Dinuzulu Hospital
Jul 19, 2022
Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with
Not yet recruiting
- Tuberculosis, Pulmonary
- Short Regimen with Rifapentine 10mg/kg
- +3 more
-
Guiyang, Guizhou, China
- +5 more
May 28, 2022
Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)
Recruiting
- Tuberculosis
- +2 more
- N acetyl cysteine
-
Bangkok, ThailandFaculty of Medicine, Siriraj Hospital
Feb 12, 2023
Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)
Not yet recruiting
- Drug Resistant Tuberculosis
- Nurse-Led Treatment in Primary Care
- (no location specified)
Dec 20, 2022
MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)
Recruiting
- MDR-TB
- Immunotherapy
- Vγ2Vδ2 T lymphocyte-based immunotherapy
- Treatment regimens for MDR-TB
-
Shanghai, China
- +1 more
Aug 8, 2022
Learn More About How Safe Darolutamide is Under Real-world
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- No Intervention
-
Multiple Locations, JapanMany Locations
Aug 24, 2023
Tuberculosis, Meningeal, Linezolid Trial in Bandung (Linezolid)
Recruiting
- Tuberculosis, Meningeal
- Linezolid
-
Bandung, Jawa Barat, IndonesiaHasan Sadikin General Hospital
Aug 7, 2022
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)
Completed
- Pulmonary Tuberculosis
- PA-824
- +5 more
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
May 18, 2022
TB Drugs and Bacterial Drug Resistance
Completed
- Tuberculosis
- Non-Tuberculosis Mycobacteria
-
Bethesda, Maryland
- +1 more
Mar 25, 2022
Continuous Glucose Monitoring in Diabetic Patients
Recruiting
- Tuberculosis
- Diabetes Mellitus
- TB Drug Levels
-
London, United KingdomLondon North West University NHS University Trust
Apr 7, 2022
Tuberculosis Trial in H?i Phòng (Community based TB intervention)
Not yet recruiting
- Tuberculosis
- Community based TB intervention
-
Hải Phòng, Vietnam
- +1 more
Dec 15, 2022
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid
Active, not recruiting
- Tuberculosis
- +4 more
- Bedaquiline Oral Tablet
- +7 more
-
Port Elizabeth, Eastern Cape, South Africa
- +1 more
Oct 20, 2022
Pre-XDR-TB Trial in Seoul (BPaL regimen)
Not yet recruiting
- Pre-XDR-TB
- BPaL regimen
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 19, 2022
Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for
Not yet recruiting
- Tuberculosis
- Rifampicin Resistant Tuberculosis
- Pretomanid
- Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
-
Rio De Janeiro, Brazil
- +6 more
Oct 18, 2022
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022